On April 30, 2026, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B Bulk Drug Substances List
Diet, lifestyle, genetics, and personal health history all affect how alcohol affects you individually
To succeed, companies should master the complexities of the OOP model (Figure 6) by building patient insights, partnering with digital and retail health providers, and assessing DTC models for broader use
Read more About us Expert Staff Embark on a journey of healthcare excellence with our seasoned professionals
The impact on your overall health can be truly transformative
OLeary S, Price A, Camarillo-Rodriguez L et al (2025) Impact of GLP-1 receptor agonists on idiopathic intracranial hypertension clinical and neurosurgical outcomes: a propensity-matched multi-institutional cohort study